BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 22069662)

  • 21. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
    Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
    Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
    Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
    J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the Potential Significance of the Intrinsically Disordered Regions in the Clostridiodes difficile Toxins A and B.
    El Hadidy N; Uversky VN; Sun X
    Curr Protein Pept Sci; 2022 Jul; 23(3):192-209. PubMed ID: 35585826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward
    Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A
    Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 26. Extra-Intestinal Effects of
    Tonon F; Di Bella S; Grassi G; Luzzati R; Ascenzi P; di Masi A; Zennaro C
    Cells; 2020 Dec; 9(12):. PubMed ID: 33271969
    [No Abstract]   [Full Text] [Related]  

  • 27. Adenosine receptors differentially mediate enteric glial cell death induced by
    Costa DVS; Shin JH; Goldbeck SM; Bolick DT; Mesquita FS; Loureiro AV; Rodrigues-Jesus MJ; Brito GAC; Warren CA
    Front Immunol; 2022; 13():956326. PubMed ID: 36726986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxin B is essential for virulence of Clostridium difficile.
    Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
    Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B.
    Shen E; Zhu K; Li D; Pan Z; Luo Y; Bian Q; He L; Song X; Zhen Y; Jin D; Tao L
    Commun Biol; 2020 Jul; 3(1):347. PubMed ID: 32620855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B.
    Simeon R; Jiang M; Chamoun-Emanuelli AM; Yu H; Zhang Y; Meng R; Peng Z; Jakana J; Zhang J; Feng H; Chen Z
    PLoS Biol; 2019 Jun; 17(6):e3000311. PubMed ID: 31233493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.
    Wang S; Zhu D; Sun X
    Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A leaky human colon model reveals uncoupled apical/basal cytotoxicity in early
    Ok MT; Liu J; Bliton RJ; Hinesley CM; San Pedro EET; Breau KA; Gomez-Martinez I; Burclaff J; Magness ST
    Am J Physiol Gastrointest Liver Physiol; 2023 Apr; 324(4):G262-G280. PubMed ID: 36749911
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
    Qiu H; Cassan R; Johnstone D; Han X; Joyee AG; McQuoid M; Masi A; Merluza J; Hrehorak B; Reid R; Kennedy K; Tighe B; Rak C; Leonhardt M; Dupas B; Saward L; Berry JD; Nykiforuk CL
    PLoS One; 2016; 11(6):e0157970. PubMed ID: 27336843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.
    Wang S; Heuler J; Wickramage I; Sun X
    Microbiol Spectr; 2022 Apr; 10(2):e0178821. PubMed ID: 35315695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteine Protease-Mediated Autocleavage of
    Zhang Y; Li S; Yang Z; Shi L; Yu H; Salerno-Goncalves R; Saint Fleur A; Feng H
    Cell Mol Gastroenterol Hepatol; 2018; 5(4):611-625. PubMed ID: 29930981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B.
    Letourneur O; Ottone S; Delauzun V; Bastide MC; Foussadier A
    Protein Expr Purif; 2003 Oct; 31(2):276-85. PubMed ID: 14550648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile toxin A and toxin B inhibit YAP in the colonic epithelial cells.
    Song J; Shen X; Huang Z; Liu Y; Cui L; Cui X; Liu CY
    J Biochem Mol Toxicol; 2021 Feb; 35(2):e22652. PubMed ID: 33251692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.
    Warren CA; Li Y; Calabrese GM; Freire RS; Zaja-Milatovic S; van Opstal E; Figler RA; Linden J; Guerrant RL
    Infect Immun; 2012 Dec; 80(12):4463-73. PubMed ID: 23045479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
    Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
    PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis.
    Huang J; Kelly CP; Bakirtzi K; Villafuerte Gálvez JA; Lyras D; Mileto SJ; Larcombe S; Xu H; Yang X; Shields KS; Zhu W; Zhang Y; Goldsmith JD; Patel IJ; Hansen J; Huang M; Yla-Herttuala S; Moss AC; Paredes-Sabja D; Pothoulakis C; Shah YM; Wang J; Chen X
    Nat Microbiol; 2019 Feb; 4(2):269-279. PubMed ID: 30510170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.